Leena Gandhi, M.D., Ph.D., from NYU School of Medicine (VIDEO)
Caption
Watch lead investigator Leena Gandhi, MD, PhD, from Perlmutter Cancer Center at NYU Langone Health, describe the findings of an international Phase III clinical trial that showed improved survival rates for patients with non-squamous non-small cell lung cancer who were treated with a combination of immunotherapy and chemotherapy.
Credit
Courtesy of NYU Langone Health
Usage Restrictions
None
License
Licensed content